The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Disruption of drug-resistant biofilms using de novo designed short α-helical antimicrobial peptides with idealized facial amphiphilicity
Abstract
The escalating threat of antimicrobial resistance has increased pressure to develop novel therapeutic strategies to tackle drug-resistant infections. Antimicrobial peptides have emerged as a promising class of therapeutics for various systemic and topical clinical applications. In this study, the de novo design of α-helical peptides with idealized facial amphiphilicities, based on an understanding of the pertinent features of protein secondary structures, is presented. Synthetic amphiphiles composed of the backbone sequence (X1Y1Y2X2)n, where X1 and X2 are hydrophobic residues (Leu or Ile or Trp), Y1 and Y2 are cationic residues (Lys), and n is the number repeat units (2 or 2.5 or 3), demonstrated potent broad-spectrum antimicrobial activities against clinical isolates of drug-susceptible and multi-drug resistant bacteria. Live-cell imaging revealed that the most selective peptide, (LKKL)3, promoted rapid permeabilization of bacterial membranes. Importantly, (LKKL)3 not only suppressed biofilm growth, but effectively disrupted mature biofilms after only 2 h of treatment. The peptides (LKKL)3 and (WKKW)3 suppressed the production of LPS-induced pro-inflammatory mediators to levels of unstimulated controls at low micromolar concentrations. Thus, the rational design strategies proposed herein can be implemented to develop potent, selective and multifunctional α-helical peptides to eradicate drug-resistant biofilm-associated infections. Antimicrobial peptides (AMPs) are increasingly explored as therapeutics for drug-resistant and biofilm-related infections to help expand the size and quality of the current antibiotic pipeline in the face of mounting antimicrobial resistance. Here, synthetic peptides rationally designed based upon principles governing the folding of natural α-helical AMPs, comprising the backbone sequence (X1Y1Y2X2)n, and which assemble into α-helical structures with idealized facial amphiphilicity, is presented. These multifunctional peptide amphiphiles demonstrate high bacterial selectivity, promote the disruption of pre-formed drug-resistant biofilms, and effectively neutralize endotoxins at low micromolar concentrations. Overall, the design strategies presented here could provide a useful tool for developing therapeutic peptides with broad-ranging clinical applications from the treatment and prevention of drug-resistant biofilms to the neutralization of bacterial endotoxins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
Research works printed but not linked: 40
- Liu, 2016, Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study, Lancet Infect. Dis., 16, 161, 10.1016/S1473-3099(15)00424-7 · DOI · Paper page
- Hall-Stoodley, 2004, Bacterial biofilms: from the natural environment to infectious diseases, Nat. Rev. Microbiol., 2, 95, 10.1038/nrmicro821 · DOI · Paper page
- de la Fuente-Núñez, 2013, Bacterial biofilm development as a multicellular adaptation: antibiotic resistance and new therapeutic strategies, Curr. Opin. Microbiol., 16, 580, 10.1016/j.mib.2013.06.013 · DOI · Paper page
- Hancock, 1998, Cationic peptides: a new source of antibiotics, Trends Biotechnol., 16, 82, 10.1016/S0167-7799(97)01156-6 · DOI · Paper page
- Zasloff, 2002, Antimicrobial peptides of multicellular organisms, Nature, 415, 389, 10.1038/415389a · DOI · Paper page
- Hilchie, 2013, Immune modulation by multifaceted cationic host defense (antimicrobial) peptides, Nat. Chem. Biol., 9, 761, 10.1038/nchembio.1393 · DOI · Paper page
- Wiradharma, 2013, Rationally designed α-helical broad-spectrum antimicrobial peptides with idealized facial amphiphilicity, Macromol. Rapid Commun., 34, 74, 10.1002/marc.201200534 · DOI
- Jacob, 2013, Short KR-12 analogs designed from human cathelicidin LL-37 possessing both antimicrobial and antiendotoxic activities without mammalian cell toxicity, J. Pept. Sci., 19, 700, 10.1002/psc.2552 · DOI
- Wang, 2012, Structure, dynamics, and antimicrobial and immune modulatory activities of human LL-23 and its single-residue variants mutated on the basis of homologous primate cathelicidins, Biochemistry, 51, 653, 10.1021/bi2016266 · DOI
- Deslouches, 2005, De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity, Antimicrob. Agents Chemother., 49, 316, 10.1128/AAC.49.1.316-322.2005 · DOI · Paper page
- Ong, 2014, Strategies employed in the design and optimization of synthetic antimicrobial peptide amphiphiles with enhanced therapeutic potentials, Adv. Drug Delivery Rev., 78, 28, 10.1016/j.addr.2014.10.013 · DOI · Paper page
- Bell, 2003, Arming the enemy: the evolution of resistance to self-proteins, Microbiology, 149, 1367, 10.1099/mic.0.26265-0 · DOI
- Hill, 2000, De novo design of helical bundles as models for understanding protein folding and function, Acc. Chem. Res., 33, 745, 10.1021/ar970004h · DOI · Paper page
- Khara, 2014, Anti-mycobacterial activities of synthetic cationic α-helical peptides and their synergism with rifampicin, Biomaterials, 35, 2032, 10.1016/j.biomaterials.2013.11.035 · doi:10.1016/j.biomaterials.2013.11.035
- Khara, 2015, Designing α-helical peptides with enhanced synergism and selectivity against Mycobacterium smegmatis: discerning the role of hydrophobicity and helicity, Acta Biomater., 28, 99, 10.1016/j.actbio.2015.09.015 · doi:10.1016/j.actbio.2015.09.015
- Wiradharma, 2011, Synthetic cationic amphiphilic α-helical peptides as antimicrobial agents, Biomaterials, 32, 2204, 10.1016/j.biomaterials.2010.11.054 · DOI · Paper page
- Pauling, 1951, The structure of proteins: two hydrogen-bonded helical configurations of the polypeptide chain, Proc. Natl. Acad. Sci. U.S.A., 37, 205, 10.1073/pnas.37.4.205 · DOI · Paper page
- Eisenberg, 1984, The hydrophobic moment detects periodicity in protein hydrophobicity, Proc. Natl. Acad. Sci. U.S.A., 81, 140, 10.1073/pnas.81.1.140 · DOI · Paper page
- DeGrado, 1985, Induction of peptide conformation at apolar water interfaces. 1. A study with model peptides of defined hydrophobic periodicity, J. Am. Chem. Soc., 107, 7684, 10.1021/ja00311a076 · DOI · Paper page
- O'Neil, 1990, A thermodynamic scale for the helix-forming tendencies of the commonly occurring amino acids, Science, 250, 646, 10.1126/science.2237415 · DOI · Paper page
- Xiong, 1995, Periodicity of polar and nonpolar amino acids is the major determinant of secondary structure in self-assembling oligomeric peptides, Proc. Natl. Acad. Sci. U.S.A., 92, 6349, 10.1073/pnas.92.14.6349 · DOI · Paper page
- Khara, 2016, Unnatural amino acid analogues of membrane-active helical peptides with anti-mycobacterial activity and improved stability, J. Antimicrob. Chemother., 71, 2181, 10.1093/jac/dkw107 · DOI
- Haney, 2015, High throughput screening methods for assessing antibiofilm and immunomodulatory activities of synthetic peptides, Peptides, 71, 276, 10.1016/j.peptides.2015.03.015 · DOI
- Segev-Zarko, 2015, Mechanisms of biofilm inhibition and degradation by antimicrobial peptides, Biochem. J., 468, 259, 10.1042/BJ20141251 · DOI
- Karsi, 2006, Development of bioluminescent Edwardsiella ictaluri for noninvasive disease monitoring, FEMS Microbiol. Lett., 260, 216, 10.1111/j.1574-6968.2006.00310.x · DOI
- Ong, 2013, Short synthetic β-sheet forming peptide amphiphiles as broad spectrum antimicrobials with antibiofilm and endotoxin neutralizing capabilities, Adv. Funct. Mater., 23, 3682, 10.1002/adfm.201202850 · DOI
- Yau, 1998, The preference of tryptophan for membrane interfaces, Biochemistry, 37, 14713, 10.1021/bi980809c · DOI · Paper page
- Hu, 2011, Designed antimicrobial and antitumor peptides with high selectivity, Biomacromolecules, 12, 3839, 10.1021/bm201098j · DOI
- Nguyen, 2010, Serum stabilities of short tryptophan-and arginine-rich antimicrobial peptide analogs, PLoS ONE, 5, e12684, 10.1371/journal.pone.0012684 · DOI · Paper page
- Deslouches, 2013, Rational design of engineered cationic antimicrobial peptides consisting exclusively of arginine and tryptophan, and their activity against multidrug-resistant pathogens, Antimicrob. Agents Chemother., 57, 2511, 10.1128/AAC.02218-12 · DOI · Paper page
- Wieprecht, 1999, Thermodynamics of the α-helix-coil transition of amphipathic peptides in a membrane environment: implications for the peptide-membrane binding equilibrium, J. Mol. Biol., 294, 785, 10.1006/jmbi.1999.3268 · DOI · Paper page
- Blondelle, 1992, Design of model amphipathic peptides having potent antimicrobial activities, Biochemistry, 31, 12688, 10.1021/bi00165a020 · DOI · Paper page
- Andrushchenko, 2007, Interactions of tryptophan-rich cathelicidin antimicrobial peptides with model membranes studied by differential scanning calorimetry, Biochim. Biophys. Acta, 1768, 2447, 10.1016/j.bbamem.2007.05.015 · DOI
- Hancock, 2006, Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies, Nat. Biotechnol., 24, 1551, 10.1038/nbt1267 · DOI · Paper page
- Hancock, 2002, Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics, Curr. Drug Targets Infect. Disord., 2, 79, 10.2174/1568005024605855 · DOI · Paper page
- Costerton, 1999, Bacterial biofilms: a common cause of persistent infections, Science, 284, 1318, 10.1126/science.284.5418.1318 · DOI · Paper page
- Cobb, 1996, Nitric oxide and septic shock, JAMA, 275, 1192, 10.1001/jama.1996.03530390058035 · DOI
- Scott, 2000, Cutting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein, J. Immunol., 164, 549, 10.4049/jimmunol.164.2.549 · DOI · Paper page
- Mookherjee, 2006, Bovine and human cathelicidin cationic host defense peptides similarly suppress transcriptional responses to bacterial lipopolysaccharide, J. Leukocyte Biol., 80, 1563, 10.1189/jlb.0106048 · DOI
- Néron, 2009, Mobyle: a new full web bioinformatics framework, Bioinformatics, 25, 3005, 10.1093/bioinformatics/btp493 · DOI · Paper page
Cited by
Antimicrobial Peptides: Classification, Design, Application and Research Progress in Multiple Fields
Huan, Y., Kong, Q., Mou, H., & Yi, H. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.582779 · Cited by 1,595
Antimicrobial peptides: Promising alternatives in the post feeding antibiotic era
Wang, J., Dou, X., Song, J., Lyu, Y., Zhu, X., Xu, L., Li, W., & Shan, A. (2019) · Medicinal Research Reviews · doi:10.1002/med.21542 · Cited by 547
Design, optimization, and nanotechnology of antimicrobial peptides: From exploration to applications
Tan, P., Fu, H., & Ma, X. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101229 · Cited by 351
Han, H., Li, S., Xu, M., Zhong, Y., Fan, W., Xu, J., Zhou, T., Ji, J., Ye, J., & Yao, K. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114770 · Cited by 322
Silica Nanoparticles—A Versatile Tool for the Treatment of Bacterial Infections
Selvarajan, V., Obuobi, S., & Ee, P. L. R. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00602 · Cited by 315
Self-citation
Metadata
- Authors
- Khara, J. S., Obuobi, S., Wang, Y., Hamilton, M. S., Robertson, B. D., Newton, S. M., Yang, Y. Y., Langford, P. R., & Ee, P. L. R.
- Venue
- Acta Biomaterialia
- Publisher
- Elsevier BV
- Published
- 2017-07
- Volume
- 57
- Pages
- 103-114
- ISSN
- 1742-7061
- Cited by
- 105
- References
- 1
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- Singapore Ministry of Health’s National Medical Research Council (NMRC/1298/2011, NMRC/OFIRG/0026/2016)
- British Society of Antimicrobial Chemotherapy
- Imperial College London Biomedical Research Centre
- Institute of Bioengineering and Nanotechnology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Disruption of drug-resistant biofilms using de novo designed short α-helical antimicrobial peptides with idealized facial amphiphilicity. https://app.cochat.ai/papers/10.1016/j.actbio.2017.04.032
- The paper
- Khara, J. S., Obuobi, S., Wang, Y., Hamilton, M. S., Robertson, B. D., Newton, S. M., Yang, Y. Y., Langford, P. R., & Ee, P. L. R. (2017). Disruption of drug-resistant biofilms using de novo designed short α-helical antimicrobial peptides with idealized facial amphiphilicity. Acta Biomaterialia. https://doi.org/10.1016/j.actbio.2017.04.032
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.